Litigation Details for MEDICURE INTERNATIONAL, INC. v. GLAND PHARMA LTD. (D.N.J. 2018)
✉ Email this page to a colleague
MEDICURE INTERNATIONAL, INC. v. GLAND PHARMA LTD. (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-11-16 |
Court | District Court, D. New Jersey | Date Terminated | 2019-08-22 |
Cause | 35:271 Patent Infringement | Assigned To | Kevin McNulty |
Jury Demand | None | Referred To | Michael A. Hammer |
Parties | MEDICURE INTERNATIONAL, INC. | ||
Patents | 6,136,794; 6,770,660 | ||
Attorneys | JEFFREY S. SOOS | ||
Firms | Haug Partners LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MEDICURE INTERNATIONAL, INC. v. GLAND PHARMA LTD.
Details for MEDICURE INTERNATIONAL, INC. v. GLAND PHARMA LTD. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | 1 | Orange-Book-listed patents, including U.S. Patent No. 6,136,794 and the ’660 patent. …States Code, involving U.S. Patent No. 6,770,660 (“the ’660 patent” or “the patent in suit”), attached hereto… This is a civil action for patent infringement arising under the patent laws of the United States, … issued by the U.S. Patent and Trademark Office on August 3, 2004. The ’660 patent was subsequently assigned…355(b)(1), the ’660 patent was submitted to FDA with NDA No. 020913. The ’660 patent was subsequently listed | External link to document | |
2019-08-22 | 45 | infringement of United Slates Patent No. 6,770,660 (the “Litigated Patent”) by the product described in…PERMANENT INJUNCTION This action for patent infringement having been brought by Plaintiff Medicure…action. 2. Claim 1-5 of the Litigated Patent are valid and enforceable in all respects. …the validity or enforceability of the Litigated Patent, are dismissed with prejudice. 4. …Defendant would infringe claims 1-5 of the Litigated Patent by making, selling, offering to sell, importing | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |